Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma

Primary effusion lymphoma (PEL) is an aggressive malignancy with poor prognosis even under chemotherapy. Kaposi sarcoma–associated herpesvirus (KSHV), one of the human oncogenic viruses, is the principal causative agent. Currently, there is no specific treatment for PEL; therefore, developing new th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood
Egile Nagusiak: Chen, Jungang, Goyal, Navneet, Dai, Lu, Lin, Zhen, Del Valle, Luis, Zabaleta, Jovanny, Liu, Jiawang, Post, Steven R., Foroozesh, Maryam, Qin, Zhiqiang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2020
Gaiak:
Lymphoid Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7645984/
https://ncbi.nlm.nih.gov/pubmed/32518949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005569
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak